ahlam1399
03-25-2016, 06:43 AM
UPDATE 3-Gilead ordered to pay Merck $200 mln in hepatitis C drug patent dispute
SAN JOSE, Calif.,/NEW YORK, March 24 (Reuters) - A federal jury on Thursday ordered Gilead Sciences Inc to pay Merck & Co $200 million in damages for infringing two Merck patents related to a lucrative cure for hepatitis C.
http://rc.feedsportal.com/r/247395869016/u/49/f/654213/c/35217/s/4e7fb02a/sc/28/rc/1/rc.img (http://rc.feedsportal.com/r/247395869016/u/49/f/654213/c/35217/s/4e7fb02a/sc/28/rc/1/rc.htm)
http://rc.feedsportal.com/r/247395869016/u/49/f/654213/c/35217/s/4e7fb02a/sc/28/rc/2/rc.img (http://rc.feedsportal.com/r/247395869016/u/49/f/654213/c/35217/s/4e7fb02a/sc/28/rc/2/rc.htm)
http://rc.feedsportal.com/r/247395869016/u/49/f/654213/c/35217/s/4e7fb02a/sc/28/rc/3/rc.img (http://rc.feedsportal.com/r/247395869016/u/49/f/654213/c/35217/s/4e7fb02a/sc/28/rc/3/rc.htm)
http://da.feedsportal.com/r/247395869016/u/49/f/654213/c/35217/s/4e7fb02a/sc/28/a2.img (http://da.feedsportal.com/r/247395869016/u/49/f/654213/c/35217/s/4e7fb02a/sc/28/a2.htm)
http://adchoice.feedsportal.com/r/247395869016/u/49/f/654213/c/35217/s/4e7fb02a/sc/28/ach.img (http://adchoice.feedsportal.com/r/247395869016/u/49/f/654213/c/35217/s/4e7fb02a/sc/28/ach.htm)http://pi.feedsportal.com/r/247395869016/u/49/f/654213/c/35217/s/4e7fb02a/sc/28/a2t.imghttp://pi2.feedsportal.com/r/247395869016/u/49/f/654213/c/35217/s/4e7fb02a/sc/28/a2t2.imghttp://i1.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/4e7fb02a/sc/28/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=Y_I_l24eRJo:I4xIn56aQh4:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=Y_I_l24eRJo:I4xIn56aQh4:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=Y_I_l24eRJo:I4xIn56aQh4:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=Y_I_l24eRJo:I4xIn56aQh4:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=Y_I_l24eRJo:I4xIn56aQh4:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/Y_I_l24eRJo
SAN JOSE, Calif.,/NEW YORK, March 24 (Reuters) - A federal jury on Thursday ordered Gilead Sciences Inc to pay Merck & Co $200 million in damages for infringing two Merck patents related to a lucrative cure for hepatitis C.
http://rc.feedsportal.com/r/247395869016/u/49/f/654213/c/35217/s/4e7fb02a/sc/28/rc/1/rc.img (http://rc.feedsportal.com/r/247395869016/u/49/f/654213/c/35217/s/4e7fb02a/sc/28/rc/1/rc.htm)
http://rc.feedsportal.com/r/247395869016/u/49/f/654213/c/35217/s/4e7fb02a/sc/28/rc/2/rc.img (http://rc.feedsportal.com/r/247395869016/u/49/f/654213/c/35217/s/4e7fb02a/sc/28/rc/2/rc.htm)
http://rc.feedsportal.com/r/247395869016/u/49/f/654213/c/35217/s/4e7fb02a/sc/28/rc/3/rc.img (http://rc.feedsportal.com/r/247395869016/u/49/f/654213/c/35217/s/4e7fb02a/sc/28/rc/3/rc.htm)
http://da.feedsportal.com/r/247395869016/u/49/f/654213/c/35217/s/4e7fb02a/sc/28/a2.img (http://da.feedsportal.com/r/247395869016/u/49/f/654213/c/35217/s/4e7fb02a/sc/28/a2.htm)
http://adchoice.feedsportal.com/r/247395869016/u/49/f/654213/c/35217/s/4e7fb02a/sc/28/ach.img (http://adchoice.feedsportal.com/r/247395869016/u/49/f/654213/c/35217/s/4e7fb02a/sc/28/ach.htm)http://pi.feedsportal.com/r/247395869016/u/49/f/654213/c/35217/s/4e7fb02a/sc/28/a2t.imghttp://pi2.feedsportal.com/r/247395869016/u/49/f/654213/c/35217/s/4e7fb02a/sc/28/a2t2.imghttp://i1.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/4e7fb02a/sc/28/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=Y_I_l24eRJo:I4xIn56aQh4:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=Y_I_l24eRJo:I4xIn56aQh4:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=Y_I_l24eRJo:I4xIn56aQh4:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=Y_I_l24eRJo:I4xIn56aQh4:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=Y_I_l24eRJo:I4xIn56aQh4:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/Y_I_l24eRJo